Loading insider details...
Beta
Latest Form 4 (May 26, 2026): Grant/Award of 220,000 GERN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 26, 2026 | GERON CORP (GERN) | Grant/Award | 220,000 | n/a |
| May 18, 2026 | SOLENO THERAPEUTICS INC (SLNO) | Disposition to Issuer | 16,991 | n/a |
| Oct 22, 2025 | CASSAVA SCIENCES INC (SAVA) | Grant/Award | 53,000 | n/a |
| Jun 9, 2025 | SOLENO THERAPEUTICS INC (SLNO) | Grant/Award | 3,991 | n/a |
| May 22, 2025 | GERON CORP (GERN) | Grant/Award | 180,000 | n/a |
| Aug 16, 2024 | SOLENO THERAPEUTICS INC (SLNO) | Grant/Award | 13,000 | n/a |
| May 10, 2024 | GERON CORP (GERN) | Grant/Award | 180,000 | n/a |
| Jun 3, 2023 | GERON CORP (GERN) | Grant/Award | 125,000 | n/a |
| May 11, 2022 | GERON CORP (GERN) | Grant/Award | 125,000 | n/a |
| May 14, 2021 | GERON CORP (GERN) | Grant/Award | 83,000 | n/a |